hidden
Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: News
No Comments
FDA Asks Companies to Recall Diabetes Medication Metformin Over Cancer-Causing Chemica
Food and Drug Administration (FDA) has announced that several lots of extended-release metformin — a popular type 2 diabetes drug — contain high levels of…
By Pharmatrax Author
Category: News
No Comments
FDA recalls brain scanning device citing potential for deadly error
The U.S. Food and Drug Administration has issued its most serious type of recall for an imaging device that surgeons rely on during deep brain…
By Pharmatrax Author
Category: News
No Comments
FDA finds likely carcinogen in common diabetes drug metformin. Will recalls follow?
On the hunt for drugs contaminated with a likely carcinogen, the FDA initially tested and cleared generic diabetes med metformin. But now, after an independent lab…
By Pharmatrax Author
Category: News
No Comments
U.S. FDA Finds High Levels of Carcinogen in Diabetes Drug Metformin
The U.S Food and Drug Administration said on Wednesday it had found high levels of a possible cancer-causing impurity in some versions of the popular…
By Pharmatrax Author
Category: News
No Comments
Five Drugmakers Are Asked to Recall Tainted Diabetes Drug
U.S. regulators have asked five drugmakers whose diabetes treatments contain high levels of a chemical that can cause cancer to recall their products. The Food…
By Pharmatrax Author
Category: News
No Comments
Novartis recalls immunosuppressant Sandimmune, Neoral capsules for hazardous packaging
Novartis, like many generic drugmakers, was forced to pull copies of generic Zantac off shelves late last year after a carcinogen scare shocked the industry. Now, it’s…
